Ahmad, Taalia Aliza S.

HRN: 24-47-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
CEFUROXIME 750MG (VIAL)
01/31/2024
02/07/2024
IV
420mg
Q8H
PCAP C
Waiting Final Action 
02/03/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/03/2024
02/09/2024
PO
4ml
BID
PCAP-C
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: